Affimed
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Affimed and buy or sell other stocks, ETFs, and their options commission-free!About AFMDQ
Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs.
CEOShawn M. Leland
CEOShawn M. Leland
Employees78
Employees78
HeadquartersMannheim, Baden Wuerttemberg
HeadquartersMannheim, Baden Wuerttemberg
Founded2000
Founded2000
Employees78
Employees78
AFMDQ Key Statistics
Market cap1.52K
Market cap1.52K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume3.61K
Average volume3.61K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.10
52 Week high$0.10
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
The current Affimed(AFMDQ) stock price is $0.00, with a market capitalization of 1.52K.
Affimed(AFMDQ) stock opened on 2026-05-24 at —. The price climbed to — and dipped to —.
Affimed(AFMDQ) shares are trading with a volume of 0, against a daily average of 3.61K.
During the past year, Affimed(AFMDQ) stock moved between $0.00 at its lowest and $0.10 at its peak.
During the past year, Affimed(AFMDQ) stock moved between $0.00 at its lowest and $0.10 at its peak.
People also own
Based on the portfolios of people who own AFMDQ. This list is generated using Robinhood data, and it’s not a recommendation.